179045-86-4 basiliximab
| Nom |
basiliximab |
| Nom anglais |
basiliximab;Basiliximab [USAN]; Basiliximab; Immunoglobulin G 1 (human-mouse monoclonal CHI621 heavy chain anti-human interleukin 2 receptor), disulfide with human-mouse monoclonal CHI621 light chain, dimer; Immunoglobulin G1 (human-mouse monoclonal CHI621 heavy chain antihuman interleukin 2 receptor), disulfide with human-mouse monoclonal CHI621 light chain, dimer; Immunoglobulin G1, anti-(human interleukin 2 receptor) (human-mouse monoclonal CHI621 gamma1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer; SDZ-CHI-621; Simulect; UNII-9927MT646M; Immunoglobulin G1, anti-(human interleukin 2 receptor)(human-mouse monoclonal CHI621 gamma1-chain), disulfide with human-mouse monoclonal CHI621 light chain, dimer |
| Numéro de registre CAS |
179045-86-4 |
| Les symboles de danger |
|
| Codes des risques |
|
| Description de sécurité |
|
|
FR
CN
CZ
DE
EN
ES
GR
HU
ID
IL
IN
IR
IT
JP
KR
MY
NL
NO
PL
PT
RU
SA
TR
